# Lead4Life PPP Call 2026

**Funder:** KWF
**Budget:** €0.5M–€2M per project (total programme: €5M)
**Deadline:** 22 September 2026 (12:00 noon; full proposal phase. Matchmaking phase precedes full proposal submission.)
**Duration:** Up to 4 years
**Consortium:** Required — public-private partnership consortium; Consortium Agreement between all participants is mandatory
**Application:** 2-stage: matchmaking phase → full proposal (deadline 22 September 2026)
**Frequency:** One-off
**Eligible countries:** NL
**Official call:** https://www.kwf.nl/en/forresearchers/funding/lead4life
**Last verified:** 14 June 2026

## Eligibility & scope

Health~Holland PPP programme focused on lead-212 (Pb-212) radiopharmaceuticals for cancer treatment. Two pillars: (1) Pb-212 production & supply chain; (2) enabling technologies for clinical introduction. Proposals must include a private party (not in financial difficulty) and comply with Health~Holland PPP requirements. Consortium Agreement required. Submission via KWF GMS; unregistered institutes must register ≥6 weeks before deadline.

---

Source: [The Great Grantsby](https://grantsby.eu/grants/kwf-lead4life-ppp-call-2026) — EU grant monitoring for academic researchers. Always verify details on the funder's website before applying.